Trabectedin improves patients with drug resistant metastatic leiomyosarcoma #SGOmtg
Martee L. Hensley, MD of Memorial Sloan Kettering discusses trabectedin improves patients with drug resistant metastatic leiomyosarcoma at SGO 2016.
Author: sgo2016
Added: 03/23/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Leiomyosarcoma